Interleukin-23 receptor single nucleotide polymorphisms in ulcerative colitis. A study in Iranian populations

Clinics and Research in Hepatology and Gastroenterology

Volumn 38, Issue 3, 2014, Pages 360-365

  Ebrahimi Daryani, Nasser ^a   Najmi Varzaneh, Farnaz ^b   Hedayat, Mona ^c   Taher, Mohammad ^a   Farhadi, Elham ^a,d   Mahmoudi, Mahdi ^a   Nicknam, Mohammad Hossein ^b   Bashashati, Mohammad ^e   Rezaei, Nima ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 23;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; CASE CONTROL STUDY; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS; IRAN;

ADULT; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-23; IRAN; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84902539991     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2013.12.008     Document Type: Article

References (33)

1. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 2002, 347(6):417-429. PubMed PMID: 12167685. Epub 2002/08/09. eng.
2. Loftus E.V. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004, 126(6):1504-1517. PubMed PMID: 15168363. Epub 2004/05/29. eng.
3. Sartor R.B. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006, 3(7):390-407. PubMed PMID: 16819502. Epub 2006/07/05. eng.
4. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448(7152):427-434. PubMed PMID: 17653185. Epub 2007/07/27. eng.
5. Vermeire S., Rutgeerts P. Current status of genetics research in inflammatory bowel disease. Genes Immun 2005, 6(8):637-645. PubMed PMID: 16107869. Epub 2005/08/19. eng.
6. Orholm M., Binder V., Sorensen T.I., Rasmussen L.P., Kyvik K.O. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol 2000, 35(10):1075-1081. PubMed PMID: 11099061. Epub 2000/12/01. eng.
7. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411(6837):603-606. PubMed PMID: 11385577. Epub 2001/06/01. eng.
8. Peltekova V.D., Wintle R.F., Rubin L.A., Amos C.I., Huang Q., Gu X., et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004, 36(5):471-475. PubMed PMID: 15107849. Epub 2004/04/27. eng.
9. Arseneau K.O., Tamagawa H., Pizarro T.T., Cominelli F. Innate and adaptive immune responses related to IBD pathogenesis. Curr Gastroenterol Rep 2007, 9(6):508-512. PubMed PMID: 18377804. Epub 2008/04/02. eng.
10. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998, 115(1):182-205. PubMed PMID: 9649475. Epub 1998/07/03. eng.
11. Glas J., Seiderer J., Wetzke M., Konrad A., Torok H.P., Schmechel S., et al. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. PloS one 2007, 2(9):e819. PubMed PMID: 17786191. Pubmed Central PMCID: 1950565. Epub 2007/09/06. eng.
12. Fisher S.A., Tremelling M., Anderson C.A., Gwilliam R., Bumpstead S., Prescott N.J., et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 2008, 40(6):710-712. PubMed PMID: 18438406. Pubmed Central PMCID: 2719289. Epub 2008/04/29. eng.
13. Hayatbakhsh M.M., Zahedi M.J., Shafiepour M., Nikpoor A.R., Mohammadi M. IL-23 receptor gene rs7517847 and rs1004819 SNPs in ulcerative colitis. Iran J Immunol 2012, 9(2):128-135. PubMed PMID: 22735800. Epub 2012/06/28. eng.
14. Bouma G., Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003, 3(7):521-533. PubMed PMID: 12876555. Epub 2003/07/24. eng.
15. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24(2):179-189. PubMed PMID: 16473830. Epub 2006/02/14. eng.
16. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314(5804):1461-1463. PubMed PMID: 17068223. Epub 2006/10/28. eng.
17. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989, 170:2-6. discussion 16-9. PubMed PMID: 2617184. Epub 1989/01/01. eng.
18. Nasiri H., Forouzandeh M., Rasaee M.J. F.R. modified salting-out method: high-yield, high-quality genomic DNA extraction from whole blood using laundry detergent. J Clin Lab Anal 2005, 19(6):229-232.
19. Éric Toussirot, Fabrice Michel, Matthieu Béreau, Binda A.D. Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement. Patient Prefer Adherence 2013, 7:369-377.
20. Naser S.A., Arce M., Khaja A., Fernandez M., Naser N., Elwasila S., et al. Role of ATG16L, NOD2 and IL23R in Crohn's disease pathogenesis. World J Gastroenterol 2012, 18(5):412-424. PubMed PMID: 22346247. Pubmed Central PMCID: 3270503.
21. Beadling C., Slifka M.K. Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27. Arch Immunol Ther Exp (Warsz) 2006, 54(1):15-24. PubMed PMID: 16642253.
22. Latiano A., Palmieri O., Valvano M.R., D'Inca R., Cucchiara S., Riegler G., et al. Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy. World J Gastroenterol 2008, 14(29):4643-4651. PubMed PMID: 18698678. Pubmed Central PMCID: 2738788.
23. Zhang Z., Zheng M., Bindas J., Schwarzenberger P., Kolls J.K. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis 2006, 12(5):382-388. PubMed PMID: 16670527.
24. Franke A., McGovern D.P., Barrett J.C., Wang K., Radford-Smith G.L., Ahmad T., et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010, 42(12):1118-1125. PubMed PMID: 21102463. Pubmed Central PMCID: 3299551.
25. Ferguson L.R., Han D.Y., Fraser A.G., Huebner C., Lam W.J. IL23R and IL12B SNPs and haplotypes strongly associate with Crohn's disease risk in a New Zealand population. Gastroenterol Res Pract 2010, 539461. Epub 2010 Dec 27.
26. Illes Z., Safrany E., Peterfalvi A., Magyari L., Farago B., Pozsonyi E., et al. 3'UTR C2370A allele of the IL-23 receptor gene is associated with relapsing-remitting multiple sclerosis. Neurosci Lett 2008, 431(1):36-38. PubMed PMID: 18180107.
27. Song G.G., Bae S.C., Choi S.J., Ji J.D., YH L. Associations between interleukin-23 receptor polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Mol Biol Rep 2012, 39(12):10655-10663.
28. Hollis-Moffatt J.E., Merriman M.E., Rodger R.A., Rowley K.A., Chapman P.T., Dalbeth N., et al. Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis. Ann Rheum Dis 2009, 68(8):1340-1344.
29. Brown M.A. Breakthroughs in genetic studies of ankylosing spondylitis. Rheumatology (Oxford) 2008, 47(2):132-137. PubMed PMID: 18037607.
30. Sands B.E., Tremaine W.J., Sandborn W.J., Rutgeerts P.J., Hanauer S.B., Mayer L., et al. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis 2001, 7(2):83-88. PubMed PMID: 11383595.
31. Probert C.S., Hearing S.D., Schreiber S., Kuhbacher T., Ghosh S., Arnott I.D., et al. Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial. Gut 2003, 52(7):998-1002. PubMed PMID: 12801957. Pubmed Central PMCID: 1773722.
32. Jurgens M., Laubender R.P., Hartl F., Weidinger M., Seiderer J., Wagner J., et al. Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis. Am J Gastroenterol 2010, 105(8):1811-1819. PubMed PMID: 20197757.
33. Sandborn W.J., Feagan B.G., Fedorak R.N., Scherl E., Fleisher M.R., Katz S., et al. A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. Gastroenterology 2008, 135(4):1130-1141. PubMed PMID: 18706417.